Doug Brutlag 2011 Genomics & Medicine Doug Brutlag Professor Emeritus of Biochemistry &

Slides:



Advertisements
Similar presentations
What is an association study? Define linkage disequilibrium
Advertisements

Single Nucleotide Polymorphism And Association Studies Stat 115 Dec 12, 2006.
Maryam Nazir. Personal Genomics:  Branch of genomics concerned with the sequencing and analysis of the genome of an individual  Once sequenced, it can.
Genetic Analysis in Human Disease
Genome-wide Association Study Focus on association between SNPs and traits Tendency – Larger and larger sample size – Use of more narrowly defined phenotypes(blood.
Doug Brutlag 2011 Genomics Bioinformatics & Medicine Biochem 158/258 and HumBio 158G Doug.
The Genetics of Breast and Ovarian Cancer Susceptibility Patricia Tonin, PhD Associate Professor Depts. Medicine, Human Genetics & Oncology McGill University.
Dr. Almut Nebel Dept. of Human Genetics University of the Witwatersrand Johannesburg South Africa Significance of SNPs for human disease.
Computational Tools for Finding and Interpreting Genetic Variations Gabor T. Marth Department of Biology, Boston College
Positional Cloning LOD Sib pairs Chromosome Region Association Study Genetics Genomics Physical Mapping/ Sequencing Candidate Gene Selection/ Polymorphism.
Something related to genetics? Dr. Lars Eijssen. Bioinformatics to understand studies in genomics – São Paulo – June Image:
Single nucleotide polymorphisms and applications Usman Roshan BNFO 601.
Human Genomic Variation The Story of SNPs. Single Nucleotide Polymorphisms (SNPs)  In addition to variation in microsatellites (VNTRs), genetic variation.
What is Genetic Testing? And what is its value? Sherri J. Bale, Ph.D., FACMG President and Clinical Director GeneDx.
Clinical Applications of Whole Genome/Whole Exome Sequencing Robert L. Nussbaum, MD, FACMG Division of Genomic Medicine, UCSF AMA – November 11, 2012.
Type 2 Diabetes With type 2 diabetes, your body either resists the effects of insulin — a hormone that regulates the movement of sugar into your cells.
RFLP DNA molecular testing and DNA Typing
BioVision Alexandria 2010 Linking Genes to Disease: Leveraging the Human Genome Doug Brutlag Professor Emeritus Biochemistry & Medicine (by courtesy)
Course Overview Personalized Medicine: Understanding Your Own Genome Fall 2014.
Genome Variations & GWAS
Computational Molecular Biology Biochem 218 – BioMedical Informatics Simple Nucleotide.
Your Family Health History
Genetic Analysis in Human Disease. Learning Objectives Describe the differences between a linkage analysis and an association analysis Identify potentially.
Genetic Disorders and Genetic Testing
Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3.
Molecular and Genetic Epidemiology Kathryn Penney, ScD January 5, 2012.
Introduction to BST775: Statistical Methods for Genetic Analysis I Course master: Degui Zhi, Ph.D. Assistant professor Section on Statistical Genetics.
Chapter 13 Carrier Screening. Introduction Carrier screening involves testing of individuals for heterozygosity for genes that would produce significant.
Computational research for medical discovery at Boston College Biology Gabor T. Marth Boston College Department of Biology
Genetics-multistep tumorigenesis genomic integrity & cancer Sections from Weinberg’s ‘the biology of Cancer’ Cancer genetics and genomics Selected.
Doug Brutlag 2011 Genomics & Medicine Doug Brutlag Professor Emeritus of Biochemistry &
Conservation of genomic segments (haplotypes): The “HapMap” n In populations, it appears the the linear order of alleles (“haplotype”) is conserved in.
Pharmacogenetics & Pharmacogenomics Personalized Medicine.
CS177 Lecture 10 SNPs and Human Genetic Variation
What host factors are at play? Paul de Bakker Division of Genetics, Brigham and Women’s Hospital Broad Institute of MIT and Harvard
From Genome-Wide Association Studies to Medicine Florian Schmitzberger - CS 374 – 4/28/2009 Stanford University Biomedical Informatics
Genome-Wide Association Study (GWAS)
Personalized Medicine Dr. M. Jawad Hassan. Personalized Medicine Human Genome and SNPs What is personalized medicine? Pharmacogenetics Case study – warfarin.
Jianfeng Xu, M.D., Dr.PH Professor of Public Health and Cancer Biology Director, Program for Genetic and Molecular Epidemiology of Cancer Associate Director,
A PPROACHING THE G ENOME - G ENETIC M ARKERS, L INKAGE AND A SSOCIATION G ENETICS 202 Jon Bernstein Department of Pediatrics October 8, 2015.
In The Name of GOD Genetic Polymorphism M.Dianatpour MLD,PHD.
Computational Biology and Genomics at Boston College Biology Gabor T. Marth Department of Biology, Boston College
Familial coronary artery disease Paul Brennan Clinical Director Northern Genetics Service Newcastle Hospitals NHS Foundation Trust North East and North.
Analyzing DNA using Microarray and Next Generation Sequencing (1) Background SNP Array Basic design Applications: CNV, LOH, GWAS Deep sequencing Alignment.
Genetic Disorders and Genetic Testing © 2010 Project Lead The Way, Inc.Medical Interventions.
Unit 1 – Living Cells.  The study of the human genome  - involves sequencing DNA nucleotides  - and relating this to gene functions  In 2003, the.
An atlas of genetic influences on human blood metabolites Nature Genetics 2014 Jun;46(6)
Personal DNA Testing Melanie Wark Mackenzie Steen.
Genetic Disorders and Genetic Testing
© 2007 McGraw-Hill Higher Education. All rights reserved. Chapter 2 Genetics: You and Your Family Health History.
Genome-Wides Association Studies (GWAS) Veryan Codd.
Genetic Analysis in Human Disease Kim R. Simpfendorfer, PhD Robert S.Boas Center for Genomics & Human Genetics The Feinstein Institute for Medical Research.
1 Finding disease genes: A challenge for Medicine, Mathematics and Computer Science Andrew Collins, Professor of Genetic Epidemiology and Bioinformatics.
Doug Brutlag 2011 The impact of genomics on the future of medicine and health Muhammad Faisal 2015-Arid-3638 PhD(scholar) Biochemistry.
Power Calculations for GWAS
Single Nucleotide Polymorphisms (SNPs
How Can You Study Human Heredity?
Unit 3.
Genetic Disorders and Genetic Testing
Human Cells Human genomics
Epidemiology 101 Epidemiology is the study of the distribution and determinants of health-related states in populations Study design is a key component.
Different mode and types of inheritance
Genome-wide Associations
Type 2 Diabetes With type 2 diabetes, your body either resists the effects of insulin — a hormone that regulates the movement of sugar into your cells.
Complete Station Race Assignment…
Medical genomics BI420 Department of Biology, Boston College
Genetic Disorders and Genetic Testing
Genetic Disorders and Genetic Testing
Medical genomics BI420 Department of Biology, Boston College
Presentation transcript:

Doug Brutlag 2011 Genomics & Medicine Doug Brutlag Professor Emeritus of Biochemistry & Medicine Stanford University School of Medicine Personal Genomics The Lancet 2010, 375:

Doug Brutlag 2011 Low Heritability of Common SNPs Rare High Penetrance Variants Carry High Risk Common SNPs Carry Low Risk Multiple Variants May Increase Risk Synergistically Common SNPs Associated with Genes Containing High Risk Alleles Common SNPs Associations can Suggest Regions to Sequence in Cohorts or Trios or Subpopulations Manolio et al. Nature 461, (2009) Odds Ratio

Doug Brutlag 2011 Disease Genes are Often Enriched in Subpopulations Subpopulations are often enriched for disease alleles Subpopulations can cause synthetic SNP associations Focusing on a subpopulations will eliminate synthetic SNP associations Focusing on subpopulations eliminates need for population stratification adjustments Egypt is a haplotype heaven! –Highest frequency of genetic (SNP) variations –High numbers of genetic subpopulations due to multiple migrations and invasions –Greeks, Romans, Turks, Persians etc.

Doug Brutlag 2011 Summary of Genome-Wide Association Studies Genome-wide association studies make no assumptions about disease mechanism or cause Genome-wide association studies usually discover only genetic correlations, not causal mutations Genome-wide associations suggest: –Genes and regions one must analyze by re-sequencing for causal alleles –Subpopulations that may be enriched for causal or preventive alleles –Genes and gene products for functional and structural studies –Genes to examine for regulatory studies Genome-wide association studies coupled with proper biological and structural studies can lead to: –Unexpected causes for disease –Novel mechanisms for disease (missense mutations, regulatory changes, alternative splicing, copy number variation etc.) –Multiple genes and multiple pathways involved in disease –Novel diagnostics and prognosis –Novel treatments

Doug Brutlag 2011 Genetic Loci Associated with Hypertriglyceridemia

Doug Brutlag 2011 Novel Rare Variants in GWAS Genes for Hypertriglyceridemia

Doug Brutlag 2011 Rare Variant Accumulation in Hypertriglyceridemia

Doug Brutlag 2011 So What Can We Learn from Personal Genomics? Disease risk for common diseases –Genetic predisposition towards a disease (relative risk or odds ratio) –Genetic versus environmental contributions to disease (penetrance) –How to alter your environment and behavior to avoid the disease Disease Carrier status –Premarital genetic counseling –Preimplantation genetic diagnosis –Neonatal diagnosis Amniocentesis Chorion villus sampling (CVS) Fetal cells in pregnant mothers blood Familial traits, diseases and relationships –Known family diseases (breast cancers, colorectal cancer, lysosome storage diseases, etc.) –Paternity (10% of people do not know their true biological father) –Maternity (about 1% of people do not know their true biological mother) –Inbreeding and incest lead to increased homozygosity and recessive diseases –Orphans can find family relations Pharmacogenomics and Pharmacogenetics: Drug susceptibility –Efficacy of common drugs –Adverse reactions to common drugs Ancestry –One can follow maternal line using mitochondrial DNA SNPs –Males can follow paternal line using Y chromosome SNPs –Shared haplotypes with recent relatives (up to 5 th cousins)

Doug Brutlag andMe

Doug Brutlag andMe Kit

Doug Brutlag andMe Spittoon

Doug Brutlag andMe Sample Tube

Doug Brutlag andMe Tube in Envelope

Doug Brutlag andMe Fedex Mailer

Doug Brutlag 2011 Choice of GWAS Studies Common traits of broad interest –Prevalence of > 1% –Report Mendelian traits when possible –Focus on drug responses Avoid false discoveries –Large case-control studies > 750 cases –Highly significant expectation values (<0.01 errors) –Published in reputable journals –Studies that have been replicated May impute highly linked missing SNPs Calculate likelihood and odds ratio using customers ethnicity as detected Distinguish preliminary studies (non-replicated or smaller sample sizes) from established research.

Doug Brutlag andMe Login

Doug Brutlag andMe Disease Risks

Doug Brutlag andME Opt-In Statement

Doug Brutlag andMe Carrier Status

Doug Brutlag andMe Carrier Status for Alpha-1 Antitrypsin Deficiency

Doug Brutlag andMe Drug Responses

Doug Brutlag 2011 Clopidogrel (Plavix®) Efficacy

Doug Brutlag andMe Traits

Doug Brutlag andMe Traits

Doug Brutlag andMe Maternal Inheritance

Doug Brutlag andMe Paternal Inheritance

Doug Brutlag andMe Relative Finder

Doug Brutlag 2011 What is a Fifth CousinWhat is a Fifth Cousin?

Doug Brutlag andMe Ancestry Painting

Doug Brutlag andMe Global Similarity

Doug Brutlag andMe Ancestry Labs

Doug Brutlag andWe Discoveries

Doug Brutlag andWe Discoveries

Doug Brutlag 2011 INFORMED Medical Decisions

Doug Brutlag 2011 INFORMED for 23andMe Customers

Doug Brutlag 2011 Navigenics

Doug Brutlag 2011 Navigenics

Doug Brutlag 2011 Navigenics

Doug Brutlag 2011 Navigenics

Doug Brutlag 2011 Navigenics

Doug Brutlag 2011 Navigenics

Doug Brutlag 2011 Navigenics

Doug Brutlag 2011 Navigenics

Doug Brutlag 2011 Navigenics

Doug Brutlag 2011 Navigenics Compass Program

Doug Brutlag 2011 Navigenics Conditions Covered

Doug Brutlag 2011 DNAdirect: Clinical Genetic Testing

Doug Brutlag 2011 DNAdirect: Clinical Genetic Testing

Doug Brutlag 2011 Personal Genomics References Clinical Assessment Incorporating a Personal Genome. Ashley, E. et al. (2010) Lancet 375, Emerging genomic applications in coronary artery disease. Damani SB, Topal EJ, JACC Cardiovasc. Intervention (2011). 4: Topal EJ, JACC Cardiovasc. Intervention (2011). 4: Clinical applicability of sequence variations in genes related to drug metabolism. Stojiljkovic M, Patrinos GP, Pavlovic S. (2011) Curr Drug Metab. 1;12(5): Clinical pharmacogenetics and potential application in personalized medicine. Zhou et al., (2008) Curr Drug Metab. 9(8): Genes, mutations, and human inherited disease at the dawn of the age of personalized genomics. Cooper et al (2010) Hum Mutat. 31(6):631-55personalized genomics. Cooper et al (2010) Hum Mutat. 31(6): Web-based, participant-driven studies yield novel genetic associations for common traits. Eriksson et al. (2010) PLoS Genetics 6, e